pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,990 catalysts · 3,350 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-24×clear all
type
  • 8k filing3,350
  • grant1,368
  • device adverse event1,000
  • approval615
  • earnings582
  • device 510k476
device pma
297
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 16, 2026

    50
    ›Mar 17, 2026device 510k153d agoA Plus Biotechnology Co., Ltd. — APS Spear Locking Plate (510k cleared)Avistone Biotechnology Co Ltd

    Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoGM Dos Reis Industria e Comercio Ltda. — Super Upper Limbs Versalock Plating System (510k cleared)

    Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoParagon 28, Inc. — Grappler Suture Anchor PCFD Tether System (510k cleared)

    Product code: MBI. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoLerado Zhongshan Peaceful Cove Business Trading Co., Ltd. — Electrical Scooter (SM4226) (510k cleared)

    Product code: INI. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoSerim Research — GUARDIAN™ Quick Dip Residual Chlorine (5212) (510k cleared)

    Product code: FKJ. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoC.R. Bard, Inc. — Elyra™ Thulium Fiber Laser System and Elyra™ Plus Thulium Fiber Laser System (Laser, Fibers, and Accessories) (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoPhilips Medical Systems Nederland B.V. — EchoNavigator R5.0 (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoCala Health, Inc. — Cala kIQ Plus (510k cleared)CARDINAL HEALTH INC

    Product code: QBC. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 17, 2026device 510k153d agoK2m, Inc. — Q Pedicle Instruments (510k cleared)

    Product code: OLO. Advisory committee: Neurology. Type: Special

    full page →fda device 510k ↗
    ›Mar 17, 2026device pma153d agoRoche — cobas® EGFR Mutation Test, v2.0 (PMA supplement)

    Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoRoche Molecular Systems, Inc. — cobas® HPV (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoPulmonx Corporation — Zephyr Endobronchial Valve (EBV) System (PMA supplement)Pulmonx Corp

    Supplement type: 30-Day Notice. Product code: NJK. Advisory committee: AN. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoABBOTT MEDICAL — Navitor Transcatheter Aortic Valve Implantation System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoJenaValve Technology, Inc. — Trilogy Transcatheter Heart Valve System (PMA)

    Product code: NPT. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoRoche Molecular Systems, Inc. — cobas® HPV (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoRoche Molecular Systems, Inc. — cobas® BRAF V600 Mutation Test (PMA supplement)

    Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoRoche Molecular System, Inc. — cobas® EZH2 Mutation Test (PMA supplement)

    Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device pma153d agoRoche Molecular Systems, Inc. — cobas® KRAS Mutation Test (PMA supplement)

    Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30

    full page →fda device pma ↗
    ›Mar 17, 2026device recall153d agoStraumann USA LLC device recall (Cls II)

    Custom Abutment Ti, for Straumann RC, incl. TAN screw; Catalog Number/Art.: 027.4620; — Reason: A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr4 D (SAP #701922 / Lot 7130430). As a result, RC Titanium abutments were manufactured using the TAN Bar material on Mill-from-Bar Machine 396-06. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 17, 2026device recall153d agoStraumann USA LLC device recall (Cls II)

    Custom Abutment AS Ti, for Straumann RC, incl. TAN screw; Catalog Number/Art.: 010.5438; — Reason: A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr4 D (SAP #701922 / Lot 7130430). As a result, RC Titanium abutments were manufactured using the TAN Bar material on Mill-from-Bar Machine 396-06. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 17, 2026grant153d agoHANNOVER MEDICAL SCHOOL — The growth factor meteorin-like and its receptor KIT in heart failure

    HL grant. $29,270. PI: Lillian Hyde

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoUNIVERSITY OF CALIFORNIA BERKELEY — Robust and Scalable Machine Learning and Statistical Methods for Genomics

    GM grant. $510,183. PI: Yun S Song

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoUNIVERSITY OF ROCHESTER — A small molecule PROTAC for macular degenerationUniversity of Rochester

    NS grant. $744,451. PI: Ruchira Singh

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoDUKE UNIVERSITY — Epithelial actions of a ubiquitin editor restrict immune-regulated sodium tra...Duke University

    DK grant. $821,618. PI: Steven D Crowley

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leveraging Inpatient records to characterize the HIV Care continuum in North ...

    MH grant. $1,177,156. PI: Thibaut Davy-Mendez

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoUNIVERSITY OF WASHINGTON — Adaptive Neural control of Respiration in DrosophilaUniversity of Washington

    NS grant. $122,769. PI: Yichen Luo

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoHANNOVER MEDICAL SCHOOL — The growth factor meteorin-like and its receptor KIT in heart failure

    HL grant. $4,750. PI: Lillian Hyde

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoUNIVERSITY OF CONNECTICUT STORRS — Implantable, Degradable Drug Delivery Devices for Non-Opioid Post-Surgical Pa...

    EB grant. $39,349. PI: Kelly Anne Burke

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoBRIGHAM AND WOMEN'S HOSPITAL — SocialBit2: High-fidelity Mobile Sensing of Social Connection after StrokeBrigham and Women's Hospital

    NS grant. $716,816. PI: Amar Dhand

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoYALE UNIVERSITY — Plasma-derived astrocyte-enriched exosomes as a platform for ALS patient stra...

    NS grant. $461,197. PI: David Pitt

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — Systemic Lipid Metabolism After Aneurysmal Subarachnoid Hemorrhage (SLIM-SAH)

    NS grant. $632,144. PI: Aaron Mark Gusdon

    full page →nih reporter ↗
    ›Mar 17, 2026grant153d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — Transposon-mediated genetic manipulation of OPCs to study their role in synap...

    NS grant. $471,861. PI: David Christopher Martinelli

    full page →nih reporter ↗
    ›Mar 18, 2026approval152d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

    Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗
    ›Mar 18, 2026approval152d agoVIGABATRIN — FDA approvalVIGABATRIN

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →VIGABATRIN →fda approvals ↗
    ›Mar 18, 2026approval152d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

    Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

    Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →risankizumab →fda approvals ↗
    ›Mar 18, 2026approval152d agoIOPIDINE (APRACLONIDINE HYDROCHLORIDE) — FDA approvalHARROW, INC.

    Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoXTORO (FINAFLOXACIN) — FDA approval

    Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoXTORO (FINAFLOXACIN) — FDA approval

    Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoVIGABATRIN — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoBUSULFAN — FDA approvalWoodward Pharma Services LLC

    Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoPAROXETINE MESYLATE — FDA approvalLegacy Pharma Solutions

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoIOPIDINE (APRACLONIDINE HYDROCHLORIDE) — FDA approvalHARROW, INC.

    Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoVIGABATRIN — FDA approvalVIGABATRIN

    Sponsor: ACCORD HLTHCARE. Form: FOR SOLUTION. Route: ORAL

    full page →VIGABATRIN →fda approvals ↗
    ›Mar 18, 2026approval152d agoLISDEXAMFETAMINE DIMESYLATE — FDA approvalLISDEXAMFETAMINE DIMESYLATE

    Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL

    full page →LISDEXAMFETAMINE DIMESYLATE →fda approvals ↗
    ›Mar 18, 2026approval152d agoVIGABATRIN — FDA approvalVIGABATRIN

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →VIGABATRIN →fda approvals ↗
    ›Mar 18, 2026approval152d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Mar 18, 2026approval152d agoTRANEXAMIC ACID — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 18, 2026approval152d agoSABRIL (VIGABATRIN) — FDA approvalVIGABATRIN

    Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL

    full page →VIGABATRIN →fda approvals ↗
    ← prev
    page 26 of 160
    next →
    $LUNG1.3700-3.52%
    $AMRX18.15+5.10%
    $HROW40.03+2.98%
    $CAH235.17+1.70%
    $HROW40.03+2.98%
    $ABBV249.46-0.54%